Genetic Technologies is a leader in the development and commercialisation of genetic risk assessment technology. Their tests predict an individual’s risk of developing chronic disease. They own and operate a world class CLIA approved genetic testing laboratory and also partner with other laboratory operators internationally to ensure their world class genetic tests are available in chosen jurisdictions.
Challenge
Genetic Technologies had spent over a decade developing their market leading genetic risk assessments and were ready to launch their first two products. Raising capital was critical in getting to market and we were approached initially to help develop an investor deck for a global biotech showcase, and then to develop a suite of marketing and sales collateral for their newly formed sales team.
Solution
We worked with the key stakeholders in the business to develop a showcase presentation that balanced the appropriate content for two distinct audiences - healthcare professionals and biotech investors. On the back of this, the company obtained high quality leads and enjoyed a successful capital raise. We then turned our attention to the sales team and delivered a cutting-edge interactive sales deck for use on tablets, supported by a wide range of assets including redesigned sales brochures with updated content to align with local markets.
WE ALSO BUILT
get in touch
Interested in working with us?
If you have a new business enquiry, a project idea or simply want to have a chat and explore how we can work together, we'd love to hear from you.
